Variable expressivity of the autosomal dominant vitreoretinochoroidopathy (ADVIRC) phenotype associated with a novel variant in BEST1

References

• Marquardt A, Stöhr H, Passmore LA, Krämer F, Rivera A, Weber BH. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (best’s disease). Hum Mol Genet. 1998;7(9):1517–25. doi:10.1093/hmg/7.9.1517.
   PubMed Web of Science ®Google Scholar
• Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, Sandgren O, Forsman K, Holmgren G, Andreasson S, et al. Identification of the gene responsible for best macular dystrophy. Nat Genet. 1998;19(3):241–7. doi:10.1038/915.
   PubMed Web of Science ®Google Scholar
• Johnson AA, Guziewicz KE, Lee CJ, Kalathur RC, Pulido JS, Marmorstein LY, Marmorstein AD. Bestrophin 1 and retinal disease. Prog Retin Eye Res. 2017;58:45–69. doi:10.1016/j.preteyeres.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Boon CJF, Klevering BJ, Leroy BP, Hoyng CB, Keunen JEE, den Hollander AI. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res. 2009;28(3):187–205. doi:10.1016/j.preteyeres.2009.04.002.
   PubMed Web of Science ®Google Scholar
• Kaufman SJ, Goldberg MF, Orth DH, Fishman GA, Tessler H, Mizuno K. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1982;100(2):272–8. doi:10.1001/archopht.1982.01030030274008.
   PubMedGoogle Scholar
• Vincent A, McAlister C, VandenHoven C, Héon E. BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies. Eye. 2011;25(1):113–18. doi:10.1038/eye.2010.165.
   PubMed Web of Science ®Google Scholar
• Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, Perveen R, Reddy MA, Bhattacharya SS, Traboulsi E, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45(10):3683–9. doi:10.1167/iovs.04-0550.
   PubMed Web of Science ®Google Scholar
• Boulanger-Scemama E, Sahel JA, Mohand-Said S, Antonio A, Condroyer C, Zeitz C, Audo I. Autosomal dominant vitreoretinochoroidopathy: when molecular genetic testing helps clinical diagnosis. Retina. 2019;39(5):867–78. doi:10.1097/IAE.0000000000002041.
   PubMed Web of Science ®Google Scholar
• Burgess R, MacLaren RE, Davidson AE, Urquhart JE, Holder GE, Robson AG, Moore AT, Keefe RO, Black GCM, Manson FDC. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet. 2009;46(9):620–5. doi:10.1136/jmg.2008.059881.
   PubMed Web of Science ®Google Scholar
• Traboulsi EI, Payne JW. Autosomal dominant vitreoretinochoroidopathy. Report of the third family. Arch Ophthalmol. 1993;111(2):194–6. doi:10.1001/archopht.1993.01090020048021.
   PubMedGoogle Scholar
• François P, Puech B, Hache JC, Laffineur Q. Vitreoretinochoroidal heredo-dystrophy, microcornea, glaucoma and cataract. J Fr Ophtalmol. 1993;16(1):29–40.
   PubMedGoogle Scholar
• Lafaut BA, Loeys B, Leroy BP, Spileers W, De Laey JJ, Kestelyn P. Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol. 2001;239(8):575–82. doi:10.1007/s004170100318.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Kaufman S, Packo K, Stöhr H, Weber BHF, Goldberg MF. Long-term macular changes in the first proband of autosomal dominant vitreoretinochoroidopathy (ADVIRC) due to a newly identified mutation in BEST1. Ophthalmic Genet. 2016;37(1):102–8. doi:10.3109/13816810.2015.1039893.
   PubMed Web of Science ®Google Scholar
• Mano F, LoBue SA, Olsen TW, Marmorstein AD, Pulido JS. A novel missense mutation in BEST1 associated with an autosomal-dominant vitreoretinochoroidopathy (ADVIRC) phenotype. Ophthalmic Genet. 2018;39(6):749–53. doi:10.1080/13816810.2018.1520264.
   PubMed Web of Science ®Google Scholar
• Blair NP, Goldberg MF, Fishman GA, Salzano T. Autosomal dominant vitreoretinochoroidopathy (ADVIRC). Br J Ophthalmol. 1984;68(1):2–9. doi:10.1136/bjo.68.1.2.
   PubMed Web of Science ®Google Scholar
• Oh KT, Vallar C. Central cone dysfunction in autosomal dominant vitreoretino choroidopathy (ADVIRC). Am J Ophthalmol. 2006;141(5):940–3. doi:10.1016/j.ajo.2005.11.041.
   PubMed Web of Science ®Google Scholar
• da Palma Mm, Vargas ME, Burr A, Chen R, Pennesi ME, Weleber RG, da Palma MM, Yang P. Variable expressivity of BEST1-associated autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a three-generation pedigree. BMJ Open Ophthalmol. 2021;6(1):e000813. doi:10.1136/bmjophth-2021-000813.
   PubMed Web of Science ®Google Scholar
• Han DP, Lewandowski MF. Electro-oculography in autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1992;110(11):1563–7. doi:10.1001/archopht.1992.01080230063021.
   PubMedGoogle Scholar
• Panneman DM, Hitti-Malin RJ, Holtes LK, de Bruijn SE, Reurink J, Boonen EGM, Khan MI, Ali M, Andréasson S, De Baere E, et al. Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis. Front Cell Dev Biol. 2023;11:1112270.
   PubMed Web of Science ®Google Scholar
• Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, Kosmicki JA, Arbelaez J, Cui W, Schwartz GB, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535–48.e24. doi:10.1016/j.cell.2018.12.015.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med Off J Am Coll Med Genet. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
   Google Scholar
• Komro J, Skender S, Ross BX, Lin X. Autosomal dominant vitreoretinochoroidopathy with a novel BEST1 mutation and a review of reported mutations. Cureus. 2022;14(12):e32990. doi:10.7759/cureus.32990.
   PubMed Web of Science ®Google Scholar
• Poncet AF, Grunewald O, Vaclavik V, Meunier I, Drumare I, Pelletier V, Bocquet B, Todorova MG, Le Moing A-G, Devos A, et al. Contribution of whole-genome sequencing and transcript analysis to decipher retinal diseases associated with MFSD8 variants. Int J Mol Sci. 2022;23(8):4294. doi:10.3390/ijms23084294.
   PubMed Web of Science ®Google Scholar
• Goldberg MF, McLeod S, Tso M, Packo K, Edwards M, Bhutto IA, Baldeosingh R, Eberhart C, Weber BHF, Lutty GA. Ocular histopathology and immunohistochemical analysis in the oldest known individual with autosomal dominant vitreoretinochoroidopathy. Ophthalmol Retina. 2018;2(4):360–78. doi:10.1016/j.oret.2017.08.001.
   PubMedGoogle Scholar